Brigid Bio

Brigid Bio

Biotechnology Research

Aberdeen, Outside the US or Canada 187 followers

Novel antifungals by design

About us

Brigid Bio is a biotech spin-out from the University of Aberdeen, developing first in class antibody-based drugs as safer and efficacious treatment solutions for high-risk and drug resistant fungal infections. We have developed a unique and proprietary drug discovery platform and identified key cell wall markers as novel drug targets which are fungal pathogen specific and critical for infection and resistance. Our lead human monoclonal antibodies to these targets have proven efficacy in a ‘clinically predictive’ in vivo infection model. Brigid Bio is supported by the Scottish Enterprise High Growth Spinout Programme and led by a team of globally recognized scientific expertise and commercial experience.

Website
www.brigidbio.com
Industry
Biotechnology Research
Company size
2-10 employees
Headquarters
Aberdeen, Outside the US or Canada
Type
Privately Held
Specialties
Monoclonal antibodies, invasive fungal infections, AMR, antimicrobial resistance, anti-infectives, Biologics therapies, drug resistant fungi, infections in immunocompromised patients

Locations

  • Primary

    Foresterhill Road

    Liberty Building

    Aberdeen, Outside the US or Canada ab15 6dn, GB

    Get directions

Employees at Brigid Bio

Updates

Similar pages